Phage Therapy Market Size, Share & Trends Analysis Report By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), by Route of Administration (Oral, Topical, Rectal Route, Intravenous Route), by Targeted Bacteria (Escherichia coli, Staphylococcus aureus, Streptococcus, Pseudomonas aeruginosa, Salmonella, Other Bacteria), by Disease Indication (Urinary Tract Infections, Chronic Otitis, Dental Extraction, Chronic Ulcerative Colitis, Bone Infection, Wound and Skin Infections, Cystic Fibrosis, Other Disease Indications), By Development Stage, By Product Type, By Target Indication, By Target Pathogen, Region And Segment Forecasts, 2025-2034

Report Id: 1094 Pages: 180 Last Updated: 21 May 2025 Format: PDF / PPT / Excel / Power BI
Share With : linkedin twitter facebook

Global Phage Therapy Market is expected to grow at an 20.50% CAGR during the forecast period for 2025-2034.

Key Industry Insights & Findings from the Report:

  • The increasing number of people living with infectious illnesses is expected to fuel the growth of this market. If bacterial infections rose, the demand for phase therapy would skyrocket.
  • The phage therapy industry is expected to grow steadily, driven by increased patient numbers and increasing concerns about antibiotics.
  • North America dominated the market and accounted for a global revenue share in 2024.
  • A severe lack of qualified healthcare workers and a lack of knowledge hinders the implementation of phage therapy methods.

Phage Therapy Market

Phage therapy industry is experiencing huge research and development activities to develop products for different diseases and applications.The global phage therapy market is under development with no FDA-approved products. In the current scenario, natural phage-based products and compassionate phage therapy (CPT) are available in the market, which comprises current market revenue. Players such as Microgen (Russia), Duopharm (Germany), SES DERMA (Peru), BIOMED PERM NPO (Russia), and Phage Therapy Center are offering treatment for patients with chronic infectious diseases. However, the global phage therapy market has a tremendous opportunity to grow during the forecast period. By region, Europe dominates the market with a share of 57.0% of the global phage therapy market. Russia and Germany are the key markets holding the majority of the market for phage therapy in the region.

The market has reputed players across the globe with massive investment in clinical trials/ R&D activities. Clinical trial/product development companies in the market form strategic alliances with key pharmaceutical vendors to seek investment and tap potential markets in upcoming forecast years. Strategic alliances with contract manufacturers, the scientific community, and policymakers will enhance the development of phage therapy for clinical trials companies. The rapid increase in investment in the phage industry has been seen in recent years due to significant market opportunities in upcoming years.

Competitive Landscape

Some of The Key Players in the Phage Therapy Market:

·       Adaptive Phage Therapeutics

·       Armata Pharmaceuticals

·       BiomX (MBcure Ltd.)

·       Locus Biosciences

·       Intralytix, Inc.

·       Pherecydes Pharma

·       PhagoMed Biopharma

·       PHAXIAM Therapeutics

·       Technophage (TechnoPhage S.A.)

·       Phage International

·       Eliava BioPreparations

·       Phagelux

·       Nextbiotics

·       Micreos Human Health

·       ContraFect

·       EnBiotix

·       Proteon Pharmaceuticals

·       PhagePro, PBC

·       SNIPR Biome

·       Eligo Bioscience

Market Segmentation

The global phage therapy market is segmented on the basis of Distribution Channel, Route of Administration, Targeted Bacteria, Disease Indication and region. As per the Distribution Channel, the market is categorized into Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies. By Route of Administration, the market is divided into Oral, Topical, Rectal Route, and Intravenous Route. According to the Targeted Bacteria, the market is segmented into Escherichia coli, Staphylococcus aureus, Streptococcus, Pseudomonas aeruginosa, Salmonella, and Other Bacteria. The Disease Indication segment comprises Urinary Tract Infections, Chronic Otitis, Dental Extraction, Chronic Ulcerative Colitis, Bone Infection, Wound and Skin Infections, Cystic Fibrosis, and Other Disease Indications. Based on region, the market is studied across North America, Asia-Pacific, Europe, and LAMEA. Among that, Europe held the largest share of the market, followed by America and the Asia Pacific. On the other hand, North America is expected to dominate the market during the analysis of the forecast period.

Recent Developments:

  • In March 2024, BiomX Inc. and Adaptive Phage Therapeutics, Inc. announced they had entered into a definitive merger agreement. BiomX is a clinical-stage company that studies and develops natural and engineered phage therapies that target specific pathogenic bacteria.
  • In January 2024, Technophage, a biopharmaceutical business that focuses on developing and producing biologics, namely those derived from bacteriophages, officially announced the successful dosing of the first patient in this critical stage. This clinical trial (ID: NCT05948592) is to determine if TP-102 is effective in treating diabetic foot ulcers caused by Staphylococcus aureus, Pseudomonas, and Acinetobacter baumannii.

The Phage Therapy Market Report Scope

Report Attribute Specifications
Growth Rate CAGR CAGR of 20.5% from 2025 to 2034
Quantitative Units Representation of revenue in US$ Million and CAGR from 2025 to 2034
Historic Year 2021 to 2024
Forecast Year 2025 to 2034
Report Coverage The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends
Segments Covered By Distribution Channel, By Route of Administration, By Target Pathogen, By Target Indication, By development stage, By Product Type, 
Regional Scope North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Country Scope U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; South Korea; South East Asia; 
Competitive Landscape Armata Pharmaceuticals, Inc., BiomX (MBcure Ltd.), Eligo Bioscience, Intralytix, Inc., iNtODEWorld, Locus Biosciences, MicroPhage, Inc., TechnoPhage, Microgen Russia, Aumed, Aziya immunopreparat LLC, Sensei Biotherapeutics, Eliava BioPreparations, Nextbiotics, PhagePro, Nexabiome, Other Prominent Players
Customization Scope Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape.
Pricing and Available Payment Methods Explore pricing alternatives that are customized to your particular study requirements.
 
 
 
 

Global Phage Therapy Market Segmentation

Global Phage Therapy Market by Development Stage 

·       Preclinical

·       Phase I / II

·       Phase III

·       Compassionate / Expanded Access Use

·       Approved / Commercial (Future launches post-2027)

phage therapy

Global Phage Therapy Market Based on Route of Administration 

·       Topical / Dermal

·       Oral

·       Injectable / Intravenous

·       Inhalation / Nebulized

·       Local Instillation (e.g., bladder, sinus, wound cavity)

Global Phage Therapy Market Based on By Product Type / Mechanism

·       Monophage

·       Phage Cocktails

·       Engineered / Recombinant Phages

·       Phage-Derived Enzymes

·       Combination Products

Global Phage Therapy Market Based on By Target Indication

·       Skin & Wound Infections

·       Respiratory Tract Infections

·       Urinary Tract Infections (UTI)

·       Bone & Joint / Implant-Associated Infections

·       Bloodstream / Sepsis

·       Gastrointestinal Infections

·       Biofilm-related Chronic Infections

Global Phage Therapy Market Based on By Target Pathogen

·       Gram-Negative Bacteria

·       Gram-Positive Bacteria

·       Mixed / Other Pathogens

Global Phage Therapy Market Based on Region 

Europe Revenue (US$ Mn) Forecast 

  • U.K.
  • Germany
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe

North America 

  • U.S.
  • Canada

Asia Pacific 

  • India
  • China
  • Japan
  • South Korea
  • Australia & New Zealand

Latin America 

  • Brazil
  • Mexico
  • Rest of Latin America

Middle East & Africa 

  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa
 
 
 
 

Need specific information/chapter from the report of the custom data table, graph or complete report? Tell us more.

Research Design and Approach

This study employed a multi-step, mixed-method research approach that integrates:

  • Secondary research
  • Primary research
  • Data triangulation
  • Hybrid top-down and bottom-up modelling
  • Forecasting and scenario analysis

This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.

Secondary Research

Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.

Sources Consulted

Secondary data for the market study was gathered from multiple credible sources, including:

  • Government databases, regulatory bodies, and public institutions
  • International organizations (WHO, OECD, IMF, World Bank, etc.)
  • Commercial and paid databases
  • Industry associations, trade publications, and technical journals
  • Company annual reports, investor presentations, press releases, and SEC filings
  • Academic research papers, patents, and scientific literature
  • Previous market research publications and syndicated reports

These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.

Secondary Research

Primary Research

Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.

Stakeholders Interviewed

Primary interviews for this study involved:

  • Manufacturers and suppliers in the market value chain
  • Distributors, channel partners, and integrators
  • End-users / customers (e.g., hospitals, labs, enterprises, consumers, etc., depending on the market)
  • Industry experts, technology specialists, consultants, and regulatory professionals
  • Senior executives (CEOs, CTOs, VPs, Directors) and product managers

Interview Process

Interviews were conducted via:

  • Structured and semi-structured questionnaires
  • Telephonic and video interactions
  • Email correspondences
  • Expert consultation sessions

Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.

Data Processing, Normalization, and Validation

All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.

The data validation process included:

  • Standardization of units (currency conversions, volume units, inflation adjustments)
  • Cross-verification of data points across multiple secondary sources
  • Normalization of inconsistent datasets
  • Identification and resolution of data gaps
  • Outlier detection and removal through algorithmic and manual checks
  • Plausibility and coherence checks across segments and geographies

This ensured that the dataset used for modelling was clean, robust, and reliable.

Market Size Estimation and Data Triangulation

Bottom-Up Approach

The bottom-up approach involved aggregating segment-level data, such as:

  • Company revenues
  • Product-level sales
  • Installed base/usage volumes
  • Adoption and penetration rates
  • Pricing analysis

This method was primarily used when detailed micro-level market data were available.

Bottom Up Approach

Top-Down Approach

The top-down approach used macro-level indicators:

  • Parent market benchmarks
  • Global/regional industry trends
  • Economic indicators (GDP, demographics, spending patterns)
  • Penetration and usage ratios

This approach was used for segments where granular data were limited or inconsistent.

Hybrid Triangulation Approach

To ensure accuracy, a triangulated hybrid model was used. This included:

  • Reconciling top-down and bottom-up estimates
  • Cross-checking revenues, volumes, and pricing assumptions
  • Incorporating expert insights to validate segment splits and adoption rates

This multi-angle validation yielded the final market size.

Forecasting Framework and Scenario Modelling

Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.

Forecasting Methods

  • Time-series modelling
  • S-curve and diffusion models (for emerging technologies)
  • Driver-based forecasting (GDP, disposable income, adoption rates, regulatory changes)
  • Price elasticity models
  • Market maturity and lifecycle-based projections

Scenario Analysis

Given inherent uncertainties, three scenarios were constructed:

  • Base-Case Scenario: Expected trajectory under current conditions
  • Optimistic Scenario: High adoption, favourable regulation, strong economic tailwinds
  • Conservative Scenario: Slow adoption, regulatory delays, economic constraints

Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.

Name field cannot be blank!
Email field cannot be blank!(Use email format)
Designation field cannot be blank!
Company field cannot be blank!
Contact No field cannot be blank!
Message field cannot be blank!
9920
Security Code field cannot be blank!

Frequently Asked Questions

Global Phage Therapy Market is expected to grow at an 20.5% CAGR during the forecast period for 2025-2034.

Armata Pharmaceuticals, Inc., BiomX (MBcure Ltd.), Eligo Bioscience, Intralytix, Inc., iNtODEWorld, Locus Biosciences, MicroPhage, Inc., TechnoPhage,

By Distribution Channel, By Route of Administration, By Target Pathogen, By Target Indication, By development stage, By Product Type,  are the key segments of the Phage Therapy Market.

North America region is leading the Phage Therapy Market.
Get Sample Report Enquiry Before Buying